Boiron SA (0DTF.L)

EUR 27.0

(-0.37%)

Gross Profit Summary of Boiron SA

  • Boiron SA's latest annual gross profit in 2023 was 358.08 Million EUR , down -5.7% from previous year.
  • Boiron SA's latest quarterly gross profit in 2024 Q2 was 167.69 Million EUR , down 0.0% from previous quarter.
  • Boiron SA reported a annual gross profit of 379.72 Million EUR in annual gross profit 2022, up 15.9% from previous year.
  • Boiron SA reported a annual gross profit of 327.62 Million EUR in annual gross profit 2021, down -17.0% from previous year.
  • Boiron SA reported a quarterly gross profit of 174.91 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Boiron SA reported a quarterly gross profit of 183.16 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Boiron SA (2023 - 2001)

Historical Annual Gross Profit of Boiron SA (2023 - 2001)

Year Gross Profit Gross Profit Growth
2023 358.08 Million EUR -5.7%
2022 379.72 Million EUR 15.9%
2021 327.62 Million EUR -17.0%
2020 394.74 Million EUR -8.18%
2019 429.89 Million EUR -8.45%
2018 469.57 Million EUR -4.05%
2017 489.39 Million EUR 0.01%
2016 489.34 Million EUR 0.08%
2015 488.97 Million EUR -0.7%
2014 492.42 Million EUR -0.16%
2013 493.21 Million EUR 12.24%
2012 439.42 Million EUR 8.54%
2011 404.85 Million EUR -1.09%
2010 409.32 Million EUR -0.7%
2009 412.2 Million EUR 12.23%
2008 367.28 Million EUR 6.73%
2007 344.13 Million EUR 10.92%
2006 310.25 Million EUR 10.57%
2005 280.6 Million EUR 21.97%
2004 230.06 Million EUR -16.2%
2003 274.54 Million EUR 5.75%
2002 259.62 Million EUR 8.51%
2001 239.25 Million EUR 0.0%

Peer Gross Profit Comparison of Boiron SA

Name Gross Profit Gross Profit Difference
Laboratorios Farmaceuticos Rovi, S.A. 483.34 Million EUR 25.915%
Vetoquinol SA 291.37 Million EUR -22.892%
Valneva SE 52.83 Million EUR -577.713%
AB Science S.A. 587 Thousand EUR -60902.215%
Nanobiotix S.A. 42.35 Million EUR -745.373%
PHAXIAM Therapeutics S.A. 1.32 Million EUR -26904.751%
Vivoryon Therapeutics N.V. -3.09 Million EUR 11669.725%
BioSenic S.A. 543 Thousand EUR -65845.304%
ABIVAX Société Anonyme 3.91 Million EUR -9048.774%
Formycon AG 23.3 Million EUR -1436.507%